114 related articles for article (PubMed ID: 10344094)
1. [Other communal respiratory pathogens and new fluoroquinolones].
Cantón R; Loza E; Valdezate S; Baquero F
Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():12-21; discussion 47-52. PubMed ID: 10344094
[No Abstract] [Full Text] [Related]
2. Newer fluoroquinolones and the management of respiratory tract infections.
Karchmer AW
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S15. PubMed ID: 10984322
[No Abstract] [Full Text] [Related]
3. [Oral fluoroquinolones. Rational antibiosis as needed].
MMW Fortschr Med; 1999 Sep; 141(35):58-9. PubMed ID: 10897964
[No Abstract] [Full Text] [Related]
4. [Is trovafloxacin an antibiotic exclusively for the treatment of respiratory infections?].
Garau J
Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():43-6; discussion 47-52. PubMed ID: 10344098
[No Abstract] [Full Text] [Related]
5. [Recent fluoroquinolones. Highly effective weapons for ambulatory therapy].
Stahlmann R; Lode H
MMW Fortschr Med; 1999 Nov; 141(47):35-6. PubMed ID: 10912165
[No Abstract] [Full Text] [Related]
6. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
Iakovlev SV; Polushkina NR; Iakovlev VP
Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
[No Abstract] [Full Text] [Related]
7. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
Talan DA
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
[TBL] [Abstract][Full Text] [Related]
8. [Levofloxacin in the treatment of respiratory infections].
Iakovlev SV; Iakovlev VP
Antibiot Khimioter; 2002; 47(8):32-42. PubMed ID: 12515095
[No Abstract] [Full Text] [Related]
9. [Fluoroquinolones in the treatment of respiratory infections].
Stahlmann R
Pneumologie; 1999 Nov; 53(11):521-9. PubMed ID: 10613068
[No Abstract] [Full Text] [Related]
10. [Respiratory tract infections. Increasingly more established antibiotics fail].
MMW Fortschr Med; 2002 Oct; 144(42):65. PubMed ID: 12534005
[No Abstract] [Full Text] [Related]
11. Respiratory fluoroquinolones: differences in the details.
Mandell LA; Iannini PB; Tillotson GS
Clin Infect Dis; 2004 May; 38(9):1331-2; author reply 1332-3. PubMed ID: 15127351
[No Abstract] [Full Text] [Related]
12. Choosing the ideal antibiotic therapy and the role of the newer fluoroquinolones in respiratory tract infections.
Owens RC
Am J Manag Care; 2000 May; 6(8 Suppl):S442-7. PubMed ID: 10977484
[No Abstract] [Full Text] [Related]
13. Emerging resistance problems among respiratory tract pathogens.
Lister PD
Am J Manag Care; 2000 May; 6(8 Suppl):S409-18. PubMed ID: 10977480
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
Jones RN; Pfaller MA
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
[TBL] [Abstract][Full Text] [Related]
15. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
Pell DM
Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
[No Abstract] [Full Text] [Related]
16. Highlights on the appropriate use of fluoroquinolones in respiratory tract infections.
Blasi F; Tarsia P; Aliberti S; Santus P; Allegra L
Pulm Pharmacol Ther; 2006; 19 Suppl 1():11-9. PubMed ID: 16310389
[TBL] [Abstract][Full Text] [Related]
17. [A new generation of fluoroquinolones--new possibilities for the treatment of respiratory community-acquired infections].
Iakovlev SV
Antibiot Khimioter; 2001; 46(6):38-42. PubMed ID: 11573324
[No Abstract] [Full Text] [Related]
18. Evaluation of the clinical microbiology profile of moxifloxacin.
Krasemann C; Meyer J; Tillotson G
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S51-63. PubMed ID: 11249830
[TBL] [Abstract][Full Text] [Related]
19. Importance of atypical pathogens of community-acquired pneumonia.
Plouffe JF
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S35-9. PubMed ID: 10984326
[TBL] [Abstract][Full Text] [Related]
20. [Role of oral fluoroquinolones in patients with respiratory diseases].
Ishida T
Kekkaku; 2003 Oct; 78(10):653-9. PubMed ID: 14621574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
